Latest eBooks

Download this eBook to explore cancer epigenetic and genetic research, cell signaling in cancer, diagnosis and treatment developments, and immuno-oncology advances.

Download this eBook to learn more about which approach you should use, how to best extract high-quality DNA from your samples as well as how to analyze your data.

Download this eBook to learn more about how to link genomics with proteomics to accelerate the search for drug targets, understand COVID-Associated Multisystem Inflammatory Syndrome in children and much more.

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.

Download this eBook to explore a collection of news, articles, interviews and infographics published in 2021, handpicked by the publication’s editorial team.

Cell and gene therapies are continuing to gain popularity, with 15 now FDA approved and hundreds more in development. While these treatments are promising, managing safety and effectiveness in patients is complex.

Technological advances along with developments in molecular medicine and data science have fueled the exploration of personalized medicine, as a result, several fields are already benefiting. Download this eBook to learn more about the topic.

Cancer is reshaping our families, our communities and our world. It is among the leading causes of death globally and cancer rates are increasing for nearly every age group and indication. Despite its prevalence, there is so much left to reveal.

Download this eBook to learn more about the fight against infectious disease, bridging the gap between immune response and treatment development plus much more.

Every field of biology has a moonshot vision. Whether that be identifying a new cell type in a poorly characterized tissue, finding a lasting, effective drug target for Alzheimer’s disease or reaching 100% remission rates for immunotherapy across patients and cancer types.